老夫子传媒

漏 2024 | 老夫子传媒
Southern Oregon University
1250 Siskiyou Blvd.
Ashland, OR 97520
541.552.6301 | 800.782.6191
Listen | Discover | Engage a service of Southern Oregon University
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Dueling federal rulings leave abortion drug access in limbo, as Oregon, Washington prepare to fight back

FILE: As Idaho鈥檚 nearly total abortion ban went into effect last year, Oregon Gov. Kate Brown held a joint press conference with Planned Parenthood Columbia Willamette, reaffirming Oregon鈥檚 commitment to abortion access, Aug. 25, 2022 at the Hillman East Portland Health Center.
Kristyna Wentz-Graff
/
OPB
FILE: As Idaho鈥檚 nearly total abortion ban went into effect last year, Oregon Gov. Kate Brown held a joint press conference with Planned Parenthood Columbia Willamette, reaffirming Oregon鈥檚 commitment to abortion access, Aug. 25, 2022 at the Hillman East Portland Health Center.

A federal court in Texas has ruled that the 23-year-old FDA approval of mifepristone should be overturned. But a federal court in Washington has ruled the FDA must continue to make the drug available in some states, including Oregon and Washington, but not California..

A common abortion medication could very shortly be banned nationally, including in Oregon, after by a federal judge based in Texas.

A conservative group sued to overrule the U.S. Food and Drug Administration鈥檚 approval of mifepristone, a medication used to end a pregnancy. The drug was approved in 2000 and has proven a safe and effective way to end pregnancy when used with another medication, misoprostol.

Because the ruling overturns a federal drug approval, the medication may lack approval everywhere, regardless of a given state鈥檚 abortion laws.

However, the ruling will not go into effect for seven days, giving lawyers representing the FDA time to file an appeal.

And in a handful of states including Oregon and Washington, a second federal case may have bearing on whether or not mifepristone continues to be available.

In February, Oregon Attorney General Ellen Rosenblum and Washington Attorney General Bob Ferguson filed their own lawsuit against the FDA, alleging the agency had singled out mifepristone for excessive regulation. More than a dozen states with Democratic attorneys general have signed on to that suit, which is being heard in U.S. District Court for the Eastern District of Washington.

According to the Oregon AG鈥檚 office, the judge in that case, Thomas Rice, that enjoins the FDA from 鈥渁ltering the status quo and rights as it relates to the availability of Mifepristone鈥 in the states that have filed that lawsuit.

The AG鈥檚 office said it is working on a legal analysis of how the two rulings, which happened nearly simultaneously, should be interpreted.

鈥淭he federal judge in the eastern district of Washington JUST granted our request to preserve access to Mifepristone pending the outcome of our case. My team is carefully reviewing both orders right now, and we will have more to say soon,鈥 Rosenblum said on Twitter.

Oregon鈥檚 governor, Tina Kotek, said she was evaluating the ruling out of Texas and promised to continue to fight for reproductive freedom.

鈥淭his is a shameful, dangerous ruling that will prevent patients across the country from accessing safe, effective medication. As we sort out the impact of this ruling, hear me loud and clear: abortion is still accessible and legal in Oregon,鈥 she said.

Jack Resneck, President of the American Medical Association, also condemned the Texas decision. In a written statement, Resneck said mifepristone has been studied extensively and used by millions of people for over two decades and is proven to be safe.

鈥淪ubstituting the opinions of individual judges and courts in place of extensive, evidence-based, scientific review of efficacy and safety through well-established FDA processes is reckless and dangerous,鈥 Resneck said.

The Oregon Health Authority issued a statement Friday evening saying it was also 鈥渞eviewing the federal court decisions鈥 with the state justice department and the governor鈥檚 office. State health officials said they are 鈥渃ommitted to ensuring a full range of essential reproductive health services, including abortion.鈥

鈥淥HA wants to reassure patients and providers that mifepristone and abortion remain safe, legal and available in Oregon,鈥 the health authority鈥檚 statement concluded.

Texas Judge Matthew Kacsmaryek, who ruled in favor of the conservative group, has been called a 鈥渓ife-long right-wing activist鈥 by Oregon Sen. Ron Wyden, a Democrat. In an unprecedented move for the usually mild-mannered lawmaker, on Feb. 16 that if Kacsmaryek banned mifepristone, 鈥淧resident Biden and the FDA must ignore it.鈥

Wyden said the harm that would be caused by banning access to mifepristone would be irreparable.

鈥淭he FDA should go on just as it has for the last 23 years since it first approved mifepristone,鈥 Wyden said. 鈥淭he FDA needs to keep this medication on the market without interruption regardless of what the ruling says. Doctors and pharmacies should go about their jobs like nothing has changed.鈥

Currently, more than half of abortions in the United States are medication abortions that typically employ both mifepristone and misoprostol. The great majority of those occur before 10 weeks of pregnancy.

Mifepristone is not medically necessary to end a pregnancy with medication. Most early pregnancies can be ended with a higher dose of misoprostol alone, but it is less effective at ending a pregnancy when used alone.

Access to abortion medication and other forms of abortion care became severely limited in some states in the wake of the U.S. Supreme Court decision in Dobbs v. Jackson, which handed the responsibility for creating and enforcing abortion access laws to the states.

Fourteen states, including Idaho, are considered very or most restrictive by the Guttmacher Institute, a research and policy organization focused on expanding reproductive rights. Twelve more states are considered restrictive.

Currently, Oregon is considered the state by Guttmacher.

In anticipation of the ruling, Gov. Jay Inslee that he had ordered the Washington Department of Corrections to use its pharmacy license to buy 30,000 doses of mifepristone for patients in the state. That鈥檚 an estimated three-year supply.

This story may be updated.

Copyright 2023

Amelia Templeton is a multimedia reporter and producer for Oregon Public Broadcasting, a JPR news partner. Her reporting comes to JPR through the Northwest News Network, a collaboration between public media organizations in Oregon and Washington.